Origo was approached to develop new branding, strategy, and marketing for Synagis® to elevate awareness among healthcare professionals about this product used to treat Respiratory Syncytial Virus (RSV), a common infection that affects the lungs of premature babies. The development of this new identity strategy was met with overwhelming success.

